epigallocatechin gallate has been researched along with Cancer of Intestines in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bose, M; Hao, X; Hong, J; Ju, J; Kwon, SJ; Lambert, JD; Lee, MJ; Yang, CS | 1 |
| Al-Fageeh, M; Blum, CA; Dashwood, RH; Dashwood, WM; Díaz, GD; Ernst, M; Heath, JK; Li, Q; Orner, GA; Tebbutt, N | 1 |
| Bose, M; Carothers, AM; Hong, J; Hou, Z; Ju, J; Liao, J; Lin, Y; Liu, YY; Ma, J; Pan, Z; Shih, WJ; Yang, CS; Yang, GY; Zhou, JN | 1 |
| Bose, M; Hao, X; Husain, A; Ju, J; Lambert, JD; Park, S; Yang, CS | 1 |
| Bose, M; Hao, X; Husain, A; Ju, J; Lambert, JD; Lee, MJ; Lu, G; Park, S; Sun, Y; Wang, S; Yang, CS | 1 |
| Fujiki, H; Ohkura, Y; Okabe, S; Suganuma, M | 1 |
| Fujiki, H; Fujimoto, N; Goto, Y; Imai, K; Matsuyama, S; Nakachi, K; Okabe, S; Sueoka, E; Sueoka, N; Suganuma, M | 1 |
1 review(s) available for epigallocatechin gallate and Cancer of Intestines
| Article | Year |
|---|---|
Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1.
Topics: Animals; Anticarcinogenic Agents; Biomarkers, Tumor; Carcinoma, Squamous Cell; Catechin; Chemoprevention; Cohort Studies; Drug Synergism; Female; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Heterogeneous-Nuclear Ribonucleoprotein Group A-B; Heterogeneous-Nuclear Ribonucleoproteins; Humans; Intestinal Neoplasms; Japan; Lung Neoplasms; Male; Mice; Mice, Mutant Strains; Okadaic Acid; Oligonucleotide Array Sequence Analysis; Prospective Studies; Ribonucleoproteins; Sulindac; Tea; Tumor Cells, Cultured | 2001 |
6 other study(ies) available for epigallocatechin gallate and Cancer of Intestines
| Article | Year |
|---|---|
Effect of genistein on the bioavailability and intestinal cancer chemopreventive activity of (-)-epigallocatechin-3-gallate.
Topics: Animals; Anticarcinogenic Agents; Biological Availability; Catechin; Drug Interactions; Genistein; HT29 Cells; Humans; Intestinal Neoplasms; Male; Mice | 2008 |
Response of Apc(min) and A33 (delta N beta-cat) mutant mice to treatment with tea, sulindac, and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
Topics: Adenomatous Polyposis Coli Protein; Animals; Anti-Inflammatory Agents, Non-Steroidal; beta Catenin; Catechin; Cell Line; Cytoskeletal Proteins; Drug Combinations; Imidazoles; Intestinal Mucosa; Intestinal Neoplasms; Luciferases; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Plant Extracts; Polyps; Sulindac; Tea; Trans-Activators | 2002 |
Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (-)-epigallocatechin-3-gallate, the major catechin in green tea.
Topics: Animals; Anticarcinogenic Agents; beta Catenin; Cadherins; Caffeine; Catechin; Dinoprostone; Extracellular Signal-Regulated MAP Kinases; Female; Genes, APC; HT29 Cells; Humans; Intestinal Neoplasms; Intestine, Small; Leukotriene B4; Male; Mice; Mice, Inbred C57BL; Phospholipases A; Phosphorylation; Proto-Oncogene Proteins c-akt | 2005 |
Inhibition of tumorigenesis in ApcMin/+ mice by a combination of (-)-epigallocatechin-3-gallate and fish oil.
Topics: Adenomatous Polyposis Coli; Animals; Anticarcinogenic Agents; Catechin; Dietary Fats; Female; Fish Oils; Germ-Line Mutation; Intestinal Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic | 2007 |
Inhibition of intestinal tumorigenesis in Apc(min/+) mice by green tea polyphenols (polyphenon E) and individual catechins.
Topics: Analysis of Variance; Animals; Anticarcinogenic Agents; Beverages; Biological Availability; Catechin; Cell Division; Diet; Drug Administration Routes; Female; Genes, APC; Immunohistochemistry; Intestinal Neoplasms; Intestine, Small; Male; Mice; Mice, Inbred C57BL; Proto-Oncogene Proteins c-akt; Tea | 2007 |
Combination cancer chemoprevention with green tea extract and sulindac shown in intestinal tumor formation in Min mice.
Topics: Adenocarcinoma; Animals; Catechin; Intestinal Neoplasms; Male; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Plant Extracts; Sulindac; Tea | 2001 |